Scholarlink

Background <p>Myocardial infarction (MI), as a manifestation of acute myocardial ischemia of coronary heart disease. The aim of this study is to search for the new targets and intervention strategy for MI.</p> Methods <p>1242 MI patients and healthy people were enrolled from four medical centers. Proteomics technique was used to analyze the differential expressed proteins (DEPs) between AMI patients and healthy people. The effect and intervention effect of DEPs were investigated with gene knockout mice hypoxia/reoxygenation (H/R) cell and mitochondrial targeted siRNA. 4628 proteins and 365 DEPs were identified in MIT.</p> Results <p>High mobility group protein B3 (HMGB3) was the most obvious DEP, which was up-regulated in AMI patients compared with healthy people. Knockout or silence of HMGB3 canceled the effects of HMGB3. Triphenylphosphine (TPP)-HMGB3-siRNA (TPP-MIT-HMGB3-siRNA) could directly target myocardial mitochondria and intervene the myocardial dysfunction caused by HMGB3.</p> Conclusions <p>HMGB3 is an important biomarker and plays a critical role in acute myocardial ischemia/reperfusion (I/R) injury. TPP-MIT-HMGB3-siRNA is a powerful mean to intervene acute myocardial ischemic injury.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Targeting inhibition of HMGB3 protein transposition in cardiac mitochondria to improve myocardial ischemia reperfusion injury

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月20日

查看全文
  • Chunhua Ma,
  • Jing Wang,
  • Xiaoyong Peng,
  • Tao Li,
  • Liangming Liu

摘要

Background

Myocardial infarction (MI), as a manifestation of acute myocardial ischemia of coronary heart disease. The aim of this study is to search for the new targets and intervention strategy for MI.

Methods

1242 MI patients and healthy people were enrolled from four medical centers. Proteomics technique was used to analyze the differential expressed proteins (DEPs) between AMI patients and healthy people. The effect and intervention effect of DEPs were investigated with gene knockout mice hypoxia/reoxygenation (H/R) cell and mitochondrial targeted siRNA. 4628 proteins and 365 DEPs were identified in MIT.

Results

High mobility group protein B3 (HMGB3) was the most obvious DEP, which was up-regulated in AMI patients compared with healthy people. Knockout or silence of HMGB3 canceled the effects of HMGB3. Triphenylphosphine (TPP)-HMGB3-siRNA (TPP-MIT-HMGB3-siRNA) could directly target myocardial mitochondria and intervene the myocardial dysfunction caused by HMGB3.

Conclusions

HMGB3 is an important biomarker and plays a critical role in acute myocardial ischemia/reperfusion (I/R) injury. TPP-MIT-HMGB3-siRNA is a powerful mean to intervene acute myocardial ischemic injury.